NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 343 / 982

  1. Psychoactive substance use among students: A cross‐sectional analysis2022 · Crossref
  2. Psychoactive substance use and drug checking practices among participants at electronic dance music events in Ukraine2022 · Crossref
  3. Psychoactive substance use, internet use and mental health changes during the COVID-19 lockdown in a French population: A study of gender effect2022 · Crossref
  4. Psychoactive substances use before suicide: detailed analysis of all cases that occurred in the Brazilian Federal District in a 10-years period2022 · Crossref
  5. PSYCHOANALYSIS OF DESTRUCTIVENESS (ON THE BASIS OF V. VERESAEV'S WORK "WITHOUT A ROAD")2022 · Crossref
  6. Psychobiotics in diet: significance and applications of neuroactive and psychoactive microbial metabolites2022 · Crossref
  7. Psychocardiology in a heartbeat: cardiac complications to consider in psychopharmacology2022 · Crossref
  8. PSYCHODELIC THERAPY IN THE TREATMENT OF RESISTANT MENTAL DISORDERS2022 · OpenAlex
  9. Psychological effects and subjective experiences of ayahuasca rituals in participants of two neoshamanic centers of Uruguay2022 · OpenAlex
  10. Psychological Effects of Repetitive Transcranial Magnetic Stimulation on Individuals With Methamphetamine Use Disorder: A Systematic Review and Meta-Analysis2022 · Crossref
  11. Psychological Evaluation and Comparison of Alcohol and Marijuana users’ w.r.t Violence (Adult)2022 · Crossref
  12. Psychological Impacts on Patients with Alcohol Use Disorder: a Study in Southern Taiwan with Alcohol Use Disorders Identification Test (AUDIT) in 20202022 · Crossref
  13. Psychometric Properties of a New Decision-Making Capacity Assessment Tool for People with Substance Use Disorder: The CAT–CAT2022 · Crossref
  14. Psychonauts and Seekers: West German Entanglements in the Spiritual Turn of the Global 1960s and 1970s2022 · OpenAlex
  15. Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions2022 · Crossref
  16. Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions2022 · OpenAlex
  17. Psychopharmacology of agitation in acute psychotic and manic episodes2022 · Crossref
  18. Psychopharmacology research: Pandemic reverberations2022 · Crossref
  19. Psychosocial Factors as the Determinants of Relapse in Individuals with Substance Use Disorder2022 · Crossref
  20. Psychosocial Interventions for Alcohol and/or Drug Misuse and Use Disorders in Women: A Systematic Review2022 · Crossref
  21. Psychosocial Interventions for Prisoners with Mental and Substance Use Disorders: A Systematic Review2022 · Crossref
  22. Psychotherapeutic and neurobiological processes associated with ayahuasca’s mental health and wellbeing outcomes: a proposed model and implications for therapeutic use2022 · OpenAlex
  23. Psychotherapies Used in the Treatment of Substance Use Disorder: A Narrative Review2022 · OpenAlex
  24. Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder2022 · Crossref
  25. Psychotropic Drug Prescription in Children and Adolescents: Approved Medications in European Countries and the United States2022 · Crossref
  26. Psychotropics for Treatment of Substance Use Disorders in Adolescents: A Brief Review2022 · Crossref
  27. Public Health and Prisons: Priorities in the Age of Mass Incarceration2022 · OpenAlex
  28. Public health critical race praxis at the intersection of traffic stops and injury epidemiology2022 · Crossref
  29. Public Health Implications and Possible Sources of Lead (Pb) as a Contaminant of Poorly Regulated Kratom Products in the United States2022 · Crossref
  30. Public Health Implications of Cannabis Legalization: An Exploration of Adolescent Use and Evidence-Based Interventions2022 · Crossref
  31. Public perception of guilt and deserved punishment in medical cannabis diversion2022 · Crossref
  32. Public Perceptions of Community Pharmacy-Based Naloxone Services: A National Cross-Sectional Survey2022 · OpenAlex
  33. Public preferences for safe consumption sites for opioid use: A discrete choice experiment2022 · OpenAlex
  34. Public support for policies to regulate flavoured tobacco and e-cigarette products in rural California2022 · Crossref
  35. Puerarin Induces Molecular Details of Ferroptosis-Associated Anti-Inflammatory on RAW264.7 Macrophages2022 · Crossref
  36. Pulmonary effects of e-liquid flavors: a systematic review2022 · OpenAlex
  37. Putting out the welcome mat—A qualitative exploration of service delivery processes and procedures as barriers to treatment‐seeking for people who use alcohol and other drugs2022 · Crossref
  38. PWUD Experiences of Criminal Justice Reform: Enduring Tensions Between Policing and Harm Reduction in Baltimore, MD2022 · Crossref
  39. Pyknotic Cell Features of Buccal Mucosal Smear in Various Oral Lesions of Betel Nut Chewers2022 · Crossref
  40. Pyoluteorin and 2,4-diacetylphloroglucinol are major contributors to Pseudomonas protegens Pf-5 biocontrol against Botrytis cinerea in cannabis2022 · OpenAlex
  41. Pyrrolizidine Alkaloid Extraction and Analysis: Recent Updates2022 · Crossref
  42. Qualification of illegal drug trafficking as part of commercial products2022 · Crossref
  43. Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients2022 · Crossref
  44. Qualitative and Quantitative Analysis of Phytochemicals in some Medicinal plants of Western Himalayas2022 · Crossref
  45. Qualitative and quantitative detection and identification of two benzodiazepines based on SERS and convolutional neural network technology2022 · Crossref
  46. Qualitative exploration of public health vending machines in young adults who misuse opioids: A promising strategy to increase naloxone access in a high risk underserved population2022 · OpenAlex
  47. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA2022 · Crossref
  48. Qualitative Research on Cannabis Use Among Youth: A Methodological Review2022 · Crossref
  49. Quality Assessment of Sedative Medicinal Plants and Their Remedies2022 · Crossref
  50. Quality characteristics of probiotic yoghurt enriched with honey and by-products left after the production of hemp oil by cold pressing the seeds of Cannabis sativa L.2022 · Crossref
  51. Quality of Life among Substance Use Disorder Patients in Khyber Pakhtunkhwa, Pakistan2022 · Crossref
  52. Quality Requirements for Medicinal Cannabis and Respective Products in the European Union – Status Quo2022 · Crossref
  53. Quality Standards in State Programs Permitting Cannabis for Medical Uses2022 · Crossref
  54. Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden2022 · OpenAlex
  55. Quantifying and characterising tobacco content in the most in-demand streamed series in 10 low/middle-income countries in 20192022 · Crossref
  56. Quantifying GABA in Addiction: A Review of Proton Magnetic Resonance Spectroscopy Studies2022 · OpenAlex
  57. Quantitative tools and measurements for assessing the implementation of regulatory policies in reducing alcohol consumption and alcohol‐related harms: A scoping review2022 · Crossref
  58. Quetiapine‐induced oral ulcers2022 · Crossref
  59. Quit status and challenges of tobacco users from a tobacco cessation clinic in South India2022 · Crossref
  60. Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes2022 · OpenAlex
  61. Race Differences in the Association Between Binge Drinking and Treatment Among First-Time Justice-System-Impacted Youth2022 · Crossref
  62. Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 20192022 · OpenAlex
  63. Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic2022 · OpenAlex
  64. Racial and Ethnic Disparities in Drug Overdose Deaths in the US During the COVID-19 Pandemic2022 · OpenAlex
  65. Racial Disparities in Access to Psychedelic Treatments and Inclusion in Research Trials2022 · OpenAlex
  66. Racial Disparities in the Wake of Cannabis Legalization: Documenting Persistence and Change2022 · Crossref
  67. Racial Equity in Cannabis Policy: Diversity in the Massachusetts Adult-Use Industry at 18-months2022 · Crossref
  68. Racial/Ethnic and Gender Differences in Risk of Injury and Life-Course Drinking Patterns: Data from US National Alcohol Surveys2022 · Crossref
  69. Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007-2019.2022 · PubMed
  70. Racial/Ethnic disparities in drug use during the COVID 19 pandemic: Moderating effects of non-profit substance use disorder service expenditures2022 · Crossref
  71. Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer2022 · OpenAlex
  72. Rancang Bangun Sistem Informasi Akuntansi menggunakan Metode Incremental – Studi Kasus di Koperasi Karyawan Coca Cola SIER2022 · Crossref
  73. Randomized controlled trial of intrathecal oxytocin on speed of recovery after hip arthroplasty2022 · OpenAlex
  74. Randomized controlled trial to test the efficacy of a brief, communication-based, substance use preventive intervention for parents of adolescents: Protocol for the SUPPER Project (Substance Use Prevention Promoted by Eating family meals Regularly)2022 · Crossref
  75. Rapid Absorption of Naloxone from Eye Drops2022 · Crossref
  76. Rapid and accurate etizolam detection using surface-enhanced Raman spectroscopy for community drug checking2022 · OpenAlex
  77. Rapid changes in illegally manufactured fentanyl products and prices in the United States2022 · Crossref
  78. Rapid quantification of cannabidiol from oils by direct analysis in real time mass spectrometry2022 · Crossref
  79. Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis2022 · Crossref
  80. Rates and Predictors of Substance use in Pediatric Primary Care Clinics2022 · Crossref
  81. Rates of Discontinuation and Non-Publication of Trials for the Pharmacologic Treatment of Alcohol use Disorder2022 · Crossref
  82. Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA2022 · Crossref
  83. Rates, characteristics and toxicology of cocaine‐related deaths in Australia, 2000–20212022 · Crossref
  84. Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics2022 · OpenAlex
  85. Re-Examining Cannabidiol: Conversion to Tetrahydrocannabinol Using Only Heat2022 · Crossref
  86. Re: Effects of Abstinence Self-Efficacy and Outcome Expectancies of Tobacco Smoking on the Desire to Quit Among Saudi Women: A Cross-Sectional Mediation Analysis2022 · Crossref
  87. Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence2022 · OpenAlex
  88. Reactive and Regulative Temperament in Relation to Clinical Symptomatology and Personality Disorders in Patients with a Substance Use Disorder2022 · Crossref
  89. Reagentless Voltammetric Identification of Cocaine from Complex Powders2022 · OpenAlex
  90. Real World studies on undesirable effects of some Anti-Thrombotic Drugs in a tertiary Hospital2022 · Crossref
  91. Real-Life Clinical Experience With Cariprazine: A Systematic Review of Case Studies2022 · OpenAlex
  92. Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study2022 · OpenAlex
  93. Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study).2022 · PubMed
  94. Real-world patient characteristics, treatment patterns, efficacy and safety of intramuscular ketamine treatment: a retrospective cohort study2022 · OpenAlex
  95. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders2022 · Crossref
  96. Realist evaluation of the impact, viability and transferability of an alcohol harm reduction support programme based on mental health recovery: the Vitae study protocol2022 · Crossref
  97. Realist evaluation of three programmes aimed at reducing harm and risks associated with alcohol consumption in the Nouvelle Aquitaine region of France: the ECIAE study protocol2022 · Crossref
  98. Reasons and analysis of Coca-Cola's greenwashing2022 · Crossref
  99. Reasons for alcohol use and non-use by underage U.S. autistic youth: A qualitative study2022 · Crossref
  100. Reasons for Purchasing Cannabis From Illegal Sources in Legal Markets: Findings Among Cannabis Consumers in Canada and U.S. States, 2019–20202022 · OpenAlex